{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-018883","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2023-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.294915+00:00","generated_at":"2026-06-14T15:57:26.728229+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Processa Pharma presents at World Orphan Drug Congress on Project Optimus for rare cancers","bullets":["Dr. David Young participates in panel titled 'Clinical Development & Regulatory Panel Session: Patient focused drug development' at World Orphan Drug Congress on May 24, 2023.","Also presents Pitch and Partner presentation titled 'Applying FDA’s Project Optimus to the Next Generation of Chemotherapy Drugs Treating Rare Cancers' at 1:00 PM ET.","Presentation made available in Investors section of company website; detailed content not disclosed in this filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-018883","json":"https://secwatch.observer/filing/0001493152-23-018883.json","markdown":"https://secwatch.observer/filing/0001493152-23-018883.md","text":"https://secwatch.observer/filing/0001493152-23-018883.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315223018883/0001493152-23-018883-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315223018883/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T15:57:26.728229+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}